These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35920237)

  • 1. The relationship between cognitive clusters and telomere length in bipolar-schizophrenia spectrum disorders.
    Gurvich C; Thomas N; Hudaib AR; Van Rheenen TE; Thomas EHX; Tan EJ; Neill E; Carruthers SP; Sumner PJ; Romano-Silva M; Bozaoglu K; Kulkarni J; Rossell SL
    Psychol Med; 2023 Aug; 53(11):5119-5126. PubMed ID: 35920237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and developmental characteristics of cognitive subgroups in a transdiagnostic sample of schizophrenia spectrum disorders and bipolar disorder.
    Bora E; Verim B; Akgul O; Ildız A; Ceylan D; Alptekin K; Özerdem A; Akdede BB
    Eur Neuropsychopharmacol; 2023 Mar; 68():47-56. PubMed ID: 36640733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of telomere length and the relationship with neurocognitive functions in euthymic bipolar disorder: A cross-sectional pilot study.
    Yang X; Feng F; Gao D; Cai L; Wan C; Zhou X; Zeng Z
    J Affect Disord; 2024 Feb; 347():630-634. PubMed ID: 38065483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster.
    Kaur M; Battisti RA; Lagopoulos J; Ward PB; Hickie IB; Hermens DF
    J Psychiatry Neurosci; 2012 Sep; 37(5):313-21. PubMed ID: 22469054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.
    Ethridge LE; Soilleux M; Nakonezny PA; Reilly JL; Hill SK; Keefe RS; Gershon ES; Pearlson GD; Tamminga CA; Keshavan MS; Sweeney JA
    Schizophr Res; 2014 Nov; 159(2-3):491-8. PubMed ID: 25261042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.
    Kristian Hill S; Buchholz A; Amsbaugh H; Reilly JL; Rubin LH; Gold JM; Keefe RS; Pearlson GD; Keshavan MS; Tamminga CA; Sweeney JA
    Schizophr Res; 2015 Aug; 166(1-3):310-5. PubMed ID: 26008884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What does the Managing Emotions branch of the MSCEIT add to the MATRICS consensus cognitive battery?
    DeTore NR; Mueser KT; McGurk SR
    Schizophr Res; 2018 Jul; 197():414-420. PubMed ID: 29486955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inflammation, oxidative damage and neurocognition predict telomere length in a transdiagnostic sample stratified by global DNA methylation levels.
    Sánchez-Ortí JV; Correa-Ghisays P; Balanzá-Martínez V; Macías Saint-Gerons D; Berenguer-Pascual E; Romá-Mateo C; Victor VM; Forés-Martos J; San-Martin C; Selva-Vera G; Tabarés-Seisdedos R
    Sci Rep; 2024 Jun; 14(1):13159. PubMed ID: 38849401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Heterogeneity on the Wisconsin Card Sorting Test in Schizophrenia Spectrum Disorders: A Cluster Analytical Investigation.
    Carruthers SP; Gurvich CT; Meyer D; ; Bousman C; Everall IP; Neill E; Pantelis C; Sumner PJ; Tan EJ; Thomas EHX; Van Rheenen TE; Rossell SL
    J Int Neuropsychol Soc; 2019 Aug; 25(7):750-760. PubMed ID: 31104647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review of Studies Reporting Data-Driven Cognitive Subtypes across the Psychosis Spectrum.
    Green MJ; Girshkin L; Kremerskothen K; Watkeys O; Quidé Y
    Neuropsychol Rev; 2020 Dec; 30(4):446-460. PubMed ID: 31853717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive subgroups among newly diagnosed patients with schizophrenia spectrum or bipolar disorders: A hierarchical cluster analysis.
    Miskowiak KW; Kjærstad HL; Lemvigh CK; Ambrosen KS; Thorvald MS; Kessing LV; Glenthoj BY; Ebdrup BH; Fagerlund B
    J Psychiatr Res; 2023 Jul; 163():278-287. PubMed ID: 37244066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum.
    Van Rheenen TE; Lewandowski KE; Tan EJ; Ospina LH; Ongur D; Neill E; Gurvich C; Pantelis C; Malhotra AK; Rossell SL; Burdick KE
    Psychol Med; 2017 Jul; 47(10):1848-1864. PubMed ID: 28241891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.
    Gotra MY; Hill SK; Gershon ES; Tamminga CA; Ivleva EI; Pearlson GD; Keshavan MS; Clementz BA; McDowell JE; Buckley PF; Sweeney JA; Keedy SK
    Schizophr Res; 2020 Sep; 223():148-157. PubMed ID: 32674921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Heterogeneity across Schizophrenia and Bipolar Disorder: A Cluster Analysis of Intellectual Trajectories.
    Vaskinn A; Haatveit B; Melle I; Andreassen OA; Ueland T; Sundet K
    J Int Neuropsychol Soc; 2020 Oct; 26(9):860-872. PubMed ID: 32423506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive heterogeneity in the offspring of patients with schizophrenia or bipolar disorder: a cluster analysis across family risk.
    Valli I; Serna E; Borràs R; Ilzarbe D; Baeza I; Picouto MD; Baltasar I; Moreno D; Bernardo M; Young AH; Vieta E; Sugranyes G; Castro-Fornieles J
    J Affect Disord; 2021 Mar; 282():757-765. PubMed ID: 33601716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere length and verbal learning in bipolar disorders.
    Mlakar V; Birkenæs V; Elvsaashagen T; Ormerod MBEG; Quintana DS; Ueland T; Melle I; Lagerberg TV; Djurovic S; Martin-Ruiz C; Steen NE; Andreassen OA; Aas M
    J Affect Disord; 2023 Oct; 339():555-560. PubMed ID: 37459977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive validation of cross-diagnostic cognitive subgroups on the schizophrenia-bipolar spectrum.
    Karantonis JA; Rossell SL; Carruthers SP; Sumner P; Hughes M; Green MJ; Pantelis C; Burdick KE; Cropley V; Van Rheenen TE
    J Affect Disord; 2020 Apr; 266():710-721. PubMed ID: 32056949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder.
    Van Rheenen TE; Rossell SL
    Bipolar Disord; 2014 May; 16(3):318-25. PubMed ID: 24119238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Dickerson F; Adamos MB; Katsafanas E; Khushalani S; Origoni A; Savage CLG; Schroeder J; Schweinfurth LAB; Stallings C; Sweeney K; Yolken R
    Schizophr Res; 2016 Oct; 176(2-3):566-571. PubMed ID: 27262384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.